InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Wednesday, 05/15/2019 10:10:37 AM

Wednesday, May 15, 2019 10:10:37 AM

Post# of 8169
News: $CLRB CLR 131 Achieves 50% Overall Response Rate in Cohort 6 of Ongoing Phase 1 Study in Relapsed or Refractory Multiple Myeloma

Results demonstrated 50% partial response rate, 50% minimal response rate, and 100% disease control rate Independent Data Monitoring Committee determines dose to be safe and well tolerated and recommends study continue to Cohort 7 FLORHAM PARK, N.J., May 15, 2019 (GLOBE NEWSWIRE) -...

Find out more https://marketwirenews.com/news-releases/clr-131-achieves-50-overall-response-rate-in-cohort-6-of-ongoing-phase-1-study-in-relapsed-or-refractory-multiple-myeloma-8190654.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CLRB News